Amgen reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for Covid-19, the respiratory disease caused by the new coronavirus.
from Earnings https://ift.tt/2KMQuhy
via IFTTT
No comments:
Post a Comment